In brief, the lipid-lowering effects of statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) and the subsequent effects on atherosclerosis seem variable in ApoE−/− and LDLR−/− mice. Here, LDLR is linked to atherosclerosis.